This decreasing trend was also observed for other chemoattractants important for recruiting immune cells to disrupt tumor growth, specifically MIG (CXCL9), MIP-1ɑ (CCL3), and MIP-1β (CCL4; Fig. 3E–G). This evidence concerns the gene CCL4 and neoplasm.